Product Overview
Ipamorelin – Research‑Grade Selective GHRP Analogue for Endocrine and Growth‑Axis Pathway Investigation
Synonyms: Ipamorelin Acetate; Selective Growth Hormone‑Releasing Peptide (GHRP)
CAS Number: 170851‑70‑4
Sequence: Aib‑His‑D‑2‑Nal‑D‑Phe‑Lys‑NH₂
Molecular Weight: Approx. 711.9 Da
Form: Lyophilised powder
Purity: ≥98% (HPLC)
Use: For laboratory research only. Not for human or veterinary use.
Overview
Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone‑releasing peptide (GHRP).
In research settings, it is widely used to investigate growth hormone secretagogue receptor (GHSR‑1a) signalling, endocrine regulation, and metabolic pathways in controlled laboratory models.
Its receptor selectivity and minimal off‑target activity make it suitable for in vitro and non‑human in vivo studies examining GH‑axis modulation, peptide–receptor interactions, and neuroendocrine feedback mechanisms.
Mechanistic Insights
Preclinical research has explored Ipamorelin in relation to several biological processes:
• GHSR‑1a Activation – Studied for its selective agonist activity at the growth hormone secretagogue receptor.
• GH‑Axis Modulation – Investigated for its influence on growth hormone release in non‑human models.
• Endocrine Signalling – Examined for its involvement in hypothalamic–pituitary pathways.
• Selective Receptor Targeting – Evaluated for its reduced interaction with ACTH, cortisol, or prolactin pathways compared with earlier GHRPs.
These findings are based on published scientific literature and do not imply any therapeutic or physiological effects in humans.
Research Context
Ipamorelin is utilised exclusively within controlled laboratory environments for:
• Studies involving GH‑axis regulation and endocrine signalling
• Investigations into GHSR‑1a receptor pharmacology
• Research on neuroendocrine feedback loops and peptide–receptor interactions
• Comparative studies with GHRP‑2, GHRP‑6, and other GH secretagogues
This material is not intended for therapeutic, diagnostic, or clinical use.
Packaging & Storage
• Supplied as a sterile‑filtered, lyophilised peptide
• Store at –20°C, protected from light and moisture
• Reconstitute under sterile laboratory conditions using bacteriostatic water or a suitable research‑grade diluent
• Store reconstituted solutions at 2–8°C and use according to institutional guidelines
Additional solubility and technical documentation are available to qualified research institutions upon request.
Compliance Notice
This product is intended solely for laboratory research purposes.
It is not approved for human or veterinary administration and must not be incorporated into food, cosmetics, pharmaceuticals, or any product intended for biological exposure.
All information provided is for scientific and educational reference only. Researchers are responsible for ensuring compliance with all applicable regulations, institutional policies, and safety standards.
